PHARMACEUTICAL SECTOR AND SUSTAINABILITY
Main Article Content
Keywords
Bibliometric analysis, Bibliometrics, Pharmaceutical sector, Sustainability.
Abstract
This research performs a quantitative analysis of the scientific production on sustainability in the pharmaceutical industry, using the Scopus database and the Bibliometrix software where 99 documents published between 2002 and 2023 are examined. India stands out as the country with the highest contribution, followed by Italy and the United States. The research identifies leading authors and institutions, underlining the importance of sustainable practices in pharmaceutical supply chain management. The analysis reveals a significant growth in scientific production since 2019, reaching its peak in 2022. Key themes such as "Life cycle assessment" and "Competitiveness" are identified, and the COVID-19 pandemic as an influential factor. Co-citation networks show collaboration between researchers and highlight the main thematic lines of the field. The study concludes that sustainability is a central theme in pharmaceutical research, with an increasing focus on life cycle assessment and competitiveness, with the recommendation to foster interdisciplinary collaboration and develop more accurate methods to assess the environmental impact of pharmaceuticals. In addition, it suggests that government policies should support the integration of sustainable practices in the industry. This analysis provides a solid basis for future research and the development of sustainable strategies in the pharmaceutical sector.
References
1. Alenina, K. A., Bengoa, D. S., & Vlasova, Y. (2016). Russian high-tech pharmaceutical enterprises: reasons and factors for sustainable innovation. J. for Global Business Advancement, 9(2), 146. https://doi.org/10.1504/jgba.2016.075706
2. Aslam, M., Jabbar, S., Abbas, Q., Albathan, M., Hussain, A., & Raza, U. (2023). Leveraging ethereum platform for development of efficient tractability system in pharmaceutical supply chain. Systems, 11(4), 202. https://doi.org/10.3390/systems11040202
3. Bade, C., Olsacher, A., Boehme, P., Truebel, H., Bürger, L., & Fehring, L. (2024). Sustainability in the pharmaceutical industry—An assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corporate Social Responsibility and Environmental Management, 31(1), 224-242. https://doi.org/10.1002/csr.2564
4. Bartolo, N. S., Azzopardi, L. M., & Serracino-Inglott, A. (2021). Pharmaceuticals and the environment. Early Human Development, 155(1), 105218. https://doi.org/10.1016/j.earlhumdev.2020.105218
5. Becker, J., Manske, C., & Randl, S. (2022). Green chemistry and sustainability metrics in the pharmaceutical manufacturing sector. Current Opinion in Green and Sustainable Chemistry, 33(1), 100562. https://doi.org/10.1016/j.cogsc.2021.100562
6. Belkhir, L. y Elmeligi, A. (2018). Huella de carbono de la industria farmacéutica mundial e impacto relativo de sus principales actores. Revista de Producción Más Limpia. https://doi.org/10.1016/j.jclepro.2018.11.204
7. Breyer, F. (2002). Reimbursement and Cost Containment. PharmacoEconomics, 20(Supplement 3), 87–94. https://doi.org/10.2165/00019053-200220003-00009
8. Cespi, D., Beach, E. S., Swarr, T. E., Passarini, F., Vassura, I., Dunn, P. J., & Anastas, P. T. (2015). Life cycle inventory improvement in the pharmaceutical sector: assessment of the sustainability combining PMI and LCA tools. Green Chemistry, 17(6), 3390–3400. https://doi.org/10.1039/c5gc00424a
9. Chen, T. L., Kim, H., Pan, S. Y., Tseng, P. C., Lin, Y. P., & Chiang, P. C. (2020). Implementation of green chemistry principles in circular economy system towards sustainable development goals: Challenges and perspectives. Science of the Total Environment, 716(1), 136998. https://doi.org/10.1016/j.scitotenv.2020.136998
10. Chomać-Pierzecka, E. (2023). Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management. Sustainability, 15(11), 8889. https://doi.org/10.3390/su15118889
11. Chowdhury, R., Das, S., & Ghosh, S. (2017). CO2 Capture and Utilization (CCU) in Coal-Fired Power Plants: Prospect of In Situ Algal Cultivation. Green Energy and Technology, 231–254. https://doi.org/10.1007/978-981-10-7188-1_10
12. Daemmrich, A., & Mohanty, A. (2014). Healthcare reform in the United States and China: pharmaceutical market implications. Journal of Pharmaceutical Policy and Practice, 7(1), 1-9. https://doi.org/10.1186/2052-3211-7-9
13. Delbeke, E. I. P., Movsisyan, M., Van Geem, K. M., & Stevens, C. V. (2016). Chemical and enzymatic modification of sophorolipids. Green Chemistry, 18(1), 76–104. https://doi.org/10.1039/c5gc02187a
14. De Soete, W. (2016). Towards a Multidisciplinary Approach on Creating Value: Sustainability through the Supply Chain and ERP Systems. Systems, 4(1), 16. https://doi.org/10.3390/systems4010016
15. Dewulf, J., & Van Langenhove, H. (Eds.). (2006). Renewables-based technology: sustainability assessment. John Wiley & Sons. https://doi.org/10.1002/0470022442
16. Doroshenko, Y. A., Starikova, M. S., Somina, I. V., Malykhina, I. O., & Riapukhina, V. N. (2019). Strategic analysis of competitiveness of high-tech companies as a tool for managing the region's innovative development. Journal of Applied Engineering Science, 17(4). https://doi.org/10.5937/jaes17-22338
17. Dubey, R., & Dubey, J. (2009). Pharmaceutical product differentiation: A strategy for strengthening product pipeline and life cycle management. Journal of Medical Marketing, 9(2), 104–118. https://doi.org/10.1057/jmm.2009.10
18. Elbadawi, M., Basit, A. W., & Gaisford, S. (2023). Energy consumption and carbon footprint of 3D printing in pharmaceutical manufacture. International Journal of Pharmaceutics, 639(1), 122926. https://doi.org/10.1016/j.ijpharm.2023.122926
19. Emmanuel, B. D., Abu-Thabit, N. Y., & Ngwuluka, N. C. (2018). Responsive polyelectrolyte complexes based on natural polysaccharides for drug delivery applications. Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications, Volume 1, 267–287. https://doi.org/10.1016/b978-0-08-101997-9.00014-x
20. Ferrazzano, L., Catani, M., Cavazzini, A., Martelli, G., Corbisiero, D., Cantelmi, P., ... & Tolomelli, A. (2022). Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. Green Chemistry, 24(3), 975-1020. https://doi.org/10.1039/D1GC04387K
21. Festa, G., Kolte, A., Carli, M. R., & Rossi, M. (2021). Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis. Journal of Business & Industrial Marketing, 37(8), 1662-1674. https://hdl.handle.net/11575/137051
22. Gardas, B. B., D. Raut, R., & Narkhede, B. E. (2019). Analysing the 3PL service provider’s evaluation criteria through a sustainable approach. International Journal of Productivity and Performance Management, 68(5), 958–980. https://doi.org/10.1108/ijppm-04-2018-0154
23. Garmidolova, A., Desseva, I., Mihaylova, D., & Lante, A. (2022). Bioactive peptides from lupinus spp. seed proteins-state-of-the-art and perspectives. Applied Sciences, 12(8), 3766. https://doi.org/10.3390/app12083766
24. Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. (2020). Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. European journal of pharmaceutics and Biopharmaceutics, 147(1), 19-37. https://doi.org/10.1016/j.ejpb.2019.12.007
25. Grigoriadou, K., Krigas, N., Sarropoulou, V., Maloupa, E., & Tsoktouridis, G. (2021). Vegetative propagation and ex-situ conservation of Acantholimon androsaceum and Limonium chersonesum, two promising local endemics of Crete (Greece) available for floricultural and pharmaceutical sustainable exploitation. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 49(1), 12261-12261. https://doi.org/10.15835/nbha49112261
26. Grundy, Q., Parker, L., Wong, A., Fusire, T., Dimancesco, D., Tisocki, K., ... & Kohler, J. (2022). Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region. Globalization and Health, 18(1), 33. https://doi.org/10.1186/s12992-022-00822-8
27. He, X., & Yu, D. (2020). Research trends in life cycle assessment research: A 20-year bibliometric analysis (1999–2018). Environmental Impact Assessment Review, 85(1), 106461. https://doi.org/10.1016/j.eiar.2020.106461
28. Hosseini-Motlagh, S.-M., Nami, N., & Farshadfar, Z. (2020). Collection disruption management and channel coordination in a socially concerned closed-loop supply chain: A game theory approach. Journal of Cleaner Production, 276(1), 124173. https://doi.org/10.1016/j.jclepro.2020.124173
29. Koller, M. (2019). Switching from petro-plastics to microbial polyhydroxyalkanoates (PHA): the biotechnological escape route of choice out of the plastic predicament?. The EuroBiotech Journal, 3(1), 32-44. https://doi.org/10.2478/ebtj-2019-0004
30. Kolsi, M. C., Ananzeh, M., & Awawdeh, A. (2021). Compliance with the global reporting initiative standards in Jordan: Case study of hikma pharmaceuticals. International Journal of Sustainable Engineering, 14(6), 1572-1586. https://doi.org/10.1080/19397038.2021.1970273
31. Kumar, A., Zavadskas, E. K., Mangla, S. K., Agrawal, V., Sharma, K., & Gupta, D. (2018). When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry. International Journal of Production Research, 1–23. https://doi.org/10.1080/00207543.2018.1543969
32. Kumar, V., Bahuguna, A., Ramalingam, S., & Kim, M. (2021). Developing a sustainable bioprocess for the cleaner production of xylooligosaccharides: An approach towards lignocellulosic waste management. Journal of Cleaner Production, 316(1), 128332. https://doi.org/10.1016/j.jclepro.2021.128332
33. Li, H., Alkahtani, M. E., Basit, A. W., Elbadawi, M., & Gaisford, S. (2023). Optimizing environmental sustainability in pharmaceutical 3D printing through machine learning. International Journal of Pharmaceutics, 648(1), 123561. https://doi.org/10.1016/j.ijpharm.2023.123561
34. Li, J., & Eastgate, M. D. (2019). Making Better Decisions During Synthetic Route Design: Leveraging Prediction to Achieve Greenness-by-Design. Reaction Chemistry & Engineering. https://doi.org/10.1039/c9re00019d
35. Liew, W. T., Adhitya, A., & Srinivasan, R. (2014). Sustainability trends in the process industries: A text mining-based analysis. Computers in Industry, 65(3), 393–400. https://doi.org/10.1016/j.compind.2014.01.004
36. Lima, P. A. B., Delgado, F. C. M., dos Santos, T. L., & Florentino, A. P. (2022). Medications reverse logistics: A systematic literature review and a method for improving the Brazilian case. Cleaner Logistics and Supply Chain, 3(1), 100024. https://doi.org/10.1016/j.clscn.2021.100024
37. Malay, O. E., & Aubinet, S. (2021). Improving government and business coordination through the use of consistent SDGs indicators. A comparative analysis of national (Belgian) and business (pharma and retail) sustainability indicators. Ecological Economics, 184(1), 106991. https://doi.org/10.1016/j.ecolecon.2021.106991
38. Marinkovic, V., Bekcic, S., Pejovic, G., Sibalija, T., Majstorovic, V., & Tasic, L. (2016). An approach to TQM evaluation in pharma business. The TQM Journal, 28(5), 745–759. https://doi.org/10.1108/tqm-10-2015-0134
39. Marques, C. M., Moniz, S., de Sousa, J. P., Barbosa-Povoa, A. P., & Reklaitis, G. (2020). Decision-support challenges in the chemical-pharmaceutical industry: Findings and future research directions. Computers & Chemical Engineering, 134(1), 106672. https://doi.org/10.1016/j.compchemeng.2019.106672
40. Masri, HA y Jaaron, AAM (2017). Evaluación de prácticas ecológicas de gestión de recursos humanos en el contexto manufacturero palestino: un estudio empírico. Revista de Producción Más Limpia, 143(1), 474–489. https://doi.org/10.1016/j.jclepro.2016.12.087
41. Mehariya, S., Fratini, F., Lavecchia, R., & Zuorro, A. (2021). Green extraction of value-added compounds form microalgae: A short review on natural deep eutectic solvents (NaDES) and related pre-treatments. Journal of Environmental Chemical Engineering, 9(5), 105989. https://doi.org/10.1016/j.jece.2021.105989
42. Mihaiu, D. M., Șerban, R.-A., Opreana, A., Țichindelean, M., Brătian, V., & Barbu, L. (2021). The Impact of Mergers and Acquisitions and Sustainability on Company Performance in the Pharmaceutical Sector. Sustainability, 13(12), 6525. https://doi.org/10.3390/su13126525
43. Milanesi, M., Runfola, A., & Guercini, S. (2020). Pharmaceutical industry riding the wave of sustainability: Review and opportunities for future research. Journal of cleaner production, 261(1), 121204. https://doi.org/10.1016/j.jclepro.2020.121204
44. Miller, V., Nwokike, J., & Stergachis, A. (2012). Pharmacovigilance and global HIV/AIDS. Current Opinion in HIV and AIDS, 7(4), 299–304. https://doi.org/10.1097/coh.0b013e328354d8e7
45. Mills, M., & Kanavos, P. (2020). Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. Health Policy, 124(3), 239–251. https://doi.org/10.1016/j.healthpol.2019.12.002
46. Niño-Amézquita, J., Legotin, F., & Barbakov, O. (2017). Economic success and sustainability in pharmaceutical sector: a case of Indian SMEs. Entrepreneurship and Sustainability Issues, 5(1), 157-168. https://dx.doi.org/10.9770/jesi.2017.5.1(13)
47. Ortiz‐Avram, D., Ovcharova, N., & Engelmann, A. (2024). Dynamic capabilities for sustainability: Toward a typology based on dimensions of sustainability‐oriented innovation and stakeholder integration. Business Strategy and the Environment, 33(4), 2969-3004. https://doi.org/10.1002/bse.3630
48. Otte, E., & Rousseau, R. (2002). Social network analysis: a powerful strategy, also for the information sciences. Journal of information Science, 28(6), 441-453. https://doi.org/10.1177/016555150202800601
49. Panda, S., Kundu, K., Basaiahgari, A., Singh, A. P., Senapati, S., & Gardas, R. L. (2018). Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations. New Journal of Chemistry, 42(9), 7105–7118. https://doi.org/10.1039/c8nj00336j
50. Park, J., & Chung, E. (2021). Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea. World Development, 137(1), 105198. https://doi.org/10.1016/j.worlddev.2020.105198
51. Ramirez, J., Gallego, G., Ez, W. N. N. N., & Tirado, J. G. (2023). Blockchain Technology for Sustainable Supply Chains: A Bibliometric Study. Journal of Distribution Science, 21(6), 119-129. https://doi.org/10.15722/jds.21.06.202306.119
52. Ramírez-Duran, J. A., Niebles-Núñez, W., & García-Tirado, J. (2023). Aplicaciones bibliométricas del estudio del capital intelectual dentro de las instituciones de educación superior desde un enfoque sostenible. Saber, Ciencia y Libertad, 18(1). https://n9.cl/2ofg4
53. Sabat, K. C., Bhattacharyya, S. S., & Krishnamoorthy, B. (2022). Circular economy in pharmaceutical industry through the lens of stimulus organism response theory. European Business Review, 34(6), 936-964. https://doi.org/10.1108/EBR-02-2022-0037
54. Sarkis, M., Bernardi, A., Shah, N., & Papathanasiou, M. M. (2021). Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes, 9(3), 457. https://doi.org/10.3390/pr9030457
55. Sax, P., & Shmueli, A. (2010). Impact of pharmaceutical regulation and policies on health system performance goals in Israel. Advances in Health Economics and Health Services Research, 77–101. https://doi.org/10.1108/s0731-2199(2010)0000022007
56. Schneider, J. L., Wilson, A., & Rosenbeck, J. M. (2010). Pharmaceutical companies and sustainability: an analysis of corporate reporting. Benchmarking: An International Journal, 17(3), 421–434. https://doi.org/10.1108/14635771011049371
57. Singh, R. K., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chains: a review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3), 234–257. https://doi.org/10.1108/ijphm-10-2015-0050
58. Small, H. (1973). Co‐citation in the scientific literature: A new measure of the relationship between two documents. Journal of the American Society for information Science, 24(4), 265-269. https://doi.org/10.1002/asi.4630240406
59. Vargas, J., & González, D. (2016). Model to assess supply chain resilience. International Journal of Safety and Security Engineering, 6(2), 282-292. https://www.witpress.com/elibrary/SSE-volumes/6/2/1171
60. Vola, F., Vinci, B., Golinelli, D., Fantini, M. P., & Vainieri, M. (2020). Harnessing pharmaceutical innovation for anti-cancer drugs: Some findings from the Italian regions. Health Policy. https://doi.org/10.1016/j.healthpol.2020.07.016
61. Woutersa, O. J., & Kanavosa, P. G. (2015). Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93(1), 606-613. https://doi.org/10.2471/BLT.14.148742
62. Zaid, AA, Jaaron, AAM y Talib Bon, A. (2018). El impacto de la gestión verde de los recursos humanos y las prácticas verdes de gestión de la cadena de suministro en el desempeño sostenible: un estudio empírico. Revista de Producción Más Limpia. https://doi.org/10.1016/j.jclepro.2018.09.062
63. Zhu, Z., Wang, Q., Sun, Q., Lexchin, J., & Yang, L. (2023). Improving access to medicines and beyond: the national volume-based procurement policy in China. BMJ Global Health, 8(7), e011535. https://doi.org/10.1136/bmjgh-2022-011535
64. Zyoud, S. E. H., Al-Jabi, S. W., Sweileh, W. M., Al-Khalil, S., Alqub, M., & Awang, R. (2015). Global methaemoglobinaemia research output (1940–2013): a bibliometric analysis. Springerplus, 4(1), 1-7. https://doi.org/10.1186/s40064-015-1431-7
2. Aslam, M., Jabbar, S., Abbas, Q., Albathan, M., Hussain, A., & Raza, U. (2023). Leveraging ethereum platform for development of efficient tractability system in pharmaceutical supply chain. Systems, 11(4), 202. https://doi.org/10.3390/systems11040202
3. Bade, C., Olsacher, A., Boehme, P., Truebel, H., Bürger, L., & Fehring, L. (2024). Sustainability in the pharmaceutical industry—An assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corporate Social Responsibility and Environmental Management, 31(1), 224-242. https://doi.org/10.1002/csr.2564
4. Bartolo, N. S., Azzopardi, L. M., & Serracino-Inglott, A. (2021). Pharmaceuticals and the environment. Early Human Development, 155(1), 105218. https://doi.org/10.1016/j.earlhumdev.2020.105218
5. Becker, J., Manske, C., & Randl, S. (2022). Green chemistry and sustainability metrics in the pharmaceutical manufacturing sector. Current Opinion in Green and Sustainable Chemistry, 33(1), 100562. https://doi.org/10.1016/j.cogsc.2021.100562
6. Belkhir, L. y Elmeligi, A. (2018). Huella de carbono de la industria farmacéutica mundial e impacto relativo de sus principales actores. Revista de Producción Más Limpia. https://doi.org/10.1016/j.jclepro.2018.11.204
7. Breyer, F. (2002). Reimbursement and Cost Containment. PharmacoEconomics, 20(Supplement 3), 87–94. https://doi.org/10.2165/00019053-200220003-00009
8. Cespi, D., Beach, E. S., Swarr, T. E., Passarini, F., Vassura, I., Dunn, P. J., & Anastas, P. T. (2015). Life cycle inventory improvement in the pharmaceutical sector: assessment of the sustainability combining PMI and LCA tools. Green Chemistry, 17(6), 3390–3400. https://doi.org/10.1039/c5gc00424a
9. Chen, T. L., Kim, H., Pan, S. Y., Tseng, P. C., Lin, Y. P., & Chiang, P. C. (2020). Implementation of green chemistry principles in circular economy system towards sustainable development goals: Challenges and perspectives. Science of the Total Environment, 716(1), 136998. https://doi.org/10.1016/j.scitotenv.2020.136998
10. Chomać-Pierzecka, E. (2023). Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management. Sustainability, 15(11), 8889. https://doi.org/10.3390/su15118889
11. Chowdhury, R., Das, S., & Ghosh, S. (2017). CO2 Capture and Utilization (CCU) in Coal-Fired Power Plants: Prospect of In Situ Algal Cultivation. Green Energy and Technology, 231–254. https://doi.org/10.1007/978-981-10-7188-1_10
12. Daemmrich, A., & Mohanty, A. (2014). Healthcare reform in the United States and China: pharmaceutical market implications. Journal of Pharmaceutical Policy and Practice, 7(1), 1-9. https://doi.org/10.1186/2052-3211-7-9
13. Delbeke, E. I. P., Movsisyan, M., Van Geem, K. M., & Stevens, C. V. (2016). Chemical and enzymatic modification of sophorolipids. Green Chemistry, 18(1), 76–104. https://doi.org/10.1039/c5gc02187a
14. De Soete, W. (2016). Towards a Multidisciplinary Approach on Creating Value: Sustainability through the Supply Chain and ERP Systems. Systems, 4(1), 16. https://doi.org/10.3390/systems4010016
15. Dewulf, J., & Van Langenhove, H. (Eds.). (2006). Renewables-based technology: sustainability assessment. John Wiley & Sons. https://doi.org/10.1002/0470022442
16. Doroshenko, Y. A., Starikova, M. S., Somina, I. V., Malykhina, I. O., & Riapukhina, V. N. (2019). Strategic analysis of competitiveness of high-tech companies as a tool for managing the region's innovative development. Journal of Applied Engineering Science, 17(4). https://doi.org/10.5937/jaes17-22338
17. Dubey, R., & Dubey, J. (2009). Pharmaceutical product differentiation: A strategy for strengthening product pipeline and life cycle management. Journal of Medical Marketing, 9(2), 104–118. https://doi.org/10.1057/jmm.2009.10
18. Elbadawi, M., Basit, A. W., & Gaisford, S. (2023). Energy consumption and carbon footprint of 3D printing in pharmaceutical manufacture. International Journal of Pharmaceutics, 639(1), 122926. https://doi.org/10.1016/j.ijpharm.2023.122926
19. Emmanuel, B. D., Abu-Thabit, N. Y., & Ngwuluka, N. C. (2018). Responsive polyelectrolyte complexes based on natural polysaccharides for drug delivery applications. Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications, Volume 1, 267–287. https://doi.org/10.1016/b978-0-08-101997-9.00014-x
20. Ferrazzano, L., Catani, M., Cavazzini, A., Martelli, G., Corbisiero, D., Cantelmi, P., ... & Tolomelli, A. (2022). Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. Green Chemistry, 24(3), 975-1020. https://doi.org/10.1039/D1GC04387K
21. Festa, G., Kolte, A., Carli, M. R., & Rossi, M. (2021). Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis. Journal of Business & Industrial Marketing, 37(8), 1662-1674. https://hdl.handle.net/11575/137051
22. Gardas, B. B., D. Raut, R., & Narkhede, B. E. (2019). Analysing the 3PL service provider’s evaluation criteria through a sustainable approach. International Journal of Productivity and Performance Management, 68(5), 958–980. https://doi.org/10.1108/ijppm-04-2018-0154
23. Garmidolova, A., Desseva, I., Mihaylova, D., & Lante, A. (2022). Bioactive peptides from lupinus spp. seed proteins-state-of-the-art and perspectives. Applied Sciences, 12(8), 3766. https://doi.org/10.3390/app12083766
24. Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. (2020). Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. European journal of pharmaceutics and Biopharmaceutics, 147(1), 19-37. https://doi.org/10.1016/j.ejpb.2019.12.007
25. Grigoriadou, K., Krigas, N., Sarropoulou, V., Maloupa, E., & Tsoktouridis, G. (2021). Vegetative propagation and ex-situ conservation of Acantholimon androsaceum and Limonium chersonesum, two promising local endemics of Crete (Greece) available for floricultural and pharmaceutical sustainable exploitation. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 49(1), 12261-12261. https://doi.org/10.15835/nbha49112261
26. Grundy, Q., Parker, L., Wong, A., Fusire, T., Dimancesco, D., Tisocki, K., ... & Kohler, J. (2022). Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region. Globalization and Health, 18(1), 33. https://doi.org/10.1186/s12992-022-00822-8
27. He, X., & Yu, D. (2020). Research trends in life cycle assessment research: A 20-year bibliometric analysis (1999–2018). Environmental Impact Assessment Review, 85(1), 106461. https://doi.org/10.1016/j.eiar.2020.106461
28. Hosseini-Motlagh, S.-M., Nami, N., & Farshadfar, Z. (2020). Collection disruption management and channel coordination in a socially concerned closed-loop supply chain: A game theory approach. Journal of Cleaner Production, 276(1), 124173. https://doi.org/10.1016/j.jclepro.2020.124173
29. Koller, M. (2019). Switching from petro-plastics to microbial polyhydroxyalkanoates (PHA): the biotechnological escape route of choice out of the plastic predicament?. The EuroBiotech Journal, 3(1), 32-44. https://doi.org/10.2478/ebtj-2019-0004
30. Kolsi, M. C., Ananzeh, M., & Awawdeh, A. (2021). Compliance with the global reporting initiative standards in Jordan: Case study of hikma pharmaceuticals. International Journal of Sustainable Engineering, 14(6), 1572-1586. https://doi.org/10.1080/19397038.2021.1970273
31. Kumar, A., Zavadskas, E. K., Mangla, S. K., Agrawal, V., Sharma, K., & Gupta, D. (2018). When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry. International Journal of Production Research, 1–23. https://doi.org/10.1080/00207543.2018.1543969
32. Kumar, V., Bahuguna, A., Ramalingam, S., & Kim, M. (2021). Developing a sustainable bioprocess for the cleaner production of xylooligosaccharides: An approach towards lignocellulosic waste management. Journal of Cleaner Production, 316(1), 128332. https://doi.org/10.1016/j.jclepro.2021.128332
33. Li, H., Alkahtani, M. E., Basit, A. W., Elbadawi, M., & Gaisford, S. (2023). Optimizing environmental sustainability in pharmaceutical 3D printing through machine learning. International Journal of Pharmaceutics, 648(1), 123561. https://doi.org/10.1016/j.ijpharm.2023.123561
34. Li, J., & Eastgate, M. D. (2019). Making Better Decisions During Synthetic Route Design: Leveraging Prediction to Achieve Greenness-by-Design. Reaction Chemistry & Engineering. https://doi.org/10.1039/c9re00019d
35. Liew, W. T., Adhitya, A., & Srinivasan, R. (2014). Sustainability trends in the process industries: A text mining-based analysis. Computers in Industry, 65(3), 393–400. https://doi.org/10.1016/j.compind.2014.01.004
36. Lima, P. A. B., Delgado, F. C. M., dos Santos, T. L., & Florentino, A. P. (2022). Medications reverse logistics: A systematic literature review and a method for improving the Brazilian case. Cleaner Logistics and Supply Chain, 3(1), 100024. https://doi.org/10.1016/j.clscn.2021.100024
37. Malay, O. E., & Aubinet, S. (2021). Improving government and business coordination through the use of consistent SDGs indicators. A comparative analysis of national (Belgian) and business (pharma and retail) sustainability indicators. Ecological Economics, 184(1), 106991. https://doi.org/10.1016/j.ecolecon.2021.106991
38. Marinkovic, V., Bekcic, S., Pejovic, G., Sibalija, T., Majstorovic, V., & Tasic, L. (2016). An approach to TQM evaluation in pharma business. The TQM Journal, 28(5), 745–759. https://doi.org/10.1108/tqm-10-2015-0134
39. Marques, C. M., Moniz, S., de Sousa, J. P., Barbosa-Povoa, A. P., & Reklaitis, G. (2020). Decision-support challenges in the chemical-pharmaceutical industry: Findings and future research directions. Computers & Chemical Engineering, 134(1), 106672. https://doi.org/10.1016/j.compchemeng.2019.106672
40. Masri, HA y Jaaron, AAM (2017). Evaluación de prácticas ecológicas de gestión de recursos humanos en el contexto manufacturero palestino: un estudio empírico. Revista de Producción Más Limpia, 143(1), 474–489. https://doi.org/10.1016/j.jclepro.2016.12.087
41. Mehariya, S., Fratini, F., Lavecchia, R., & Zuorro, A. (2021). Green extraction of value-added compounds form microalgae: A short review on natural deep eutectic solvents (NaDES) and related pre-treatments. Journal of Environmental Chemical Engineering, 9(5), 105989. https://doi.org/10.1016/j.jece.2021.105989
42. Mihaiu, D. M., Șerban, R.-A., Opreana, A., Țichindelean, M., Brătian, V., & Barbu, L. (2021). The Impact of Mergers and Acquisitions and Sustainability on Company Performance in the Pharmaceutical Sector. Sustainability, 13(12), 6525. https://doi.org/10.3390/su13126525
43. Milanesi, M., Runfola, A., & Guercini, S. (2020). Pharmaceutical industry riding the wave of sustainability: Review and opportunities for future research. Journal of cleaner production, 261(1), 121204. https://doi.org/10.1016/j.jclepro.2020.121204
44. Miller, V., Nwokike, J., & Stergachis, A. (2012). Pharmacovigilance and global HIV/AIDS. Current Opinion in HIV and AIDS, 7(4), 299–304. https://doi.org/10.1097/coh.0b013e328354d8e7
45. Mills, M., & Kanavos, P. (2020). Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. Health Policy, 124(3), 239–251. https://doi.org/10.1016/j.healthpol.2019.12.002
46. Niño-Amézquita, J., Legotin, F., & Barbakov, O. (2017). Economic success and sustainability in pharmaceutical sector: a case of Indian SMEs. Entrepreneurship and Sustainability Issues, 5(1), 157-168. https://dx.doi.org/10.9770/jesi.2017.5.1(13)
47. Ortiz‐Avram, D., Ovcharova, N., & Engelmann, A. (2024). Dynamic capabilities for sustainability: Toward a typology based on dimensions of sustainability‐oriented innovation and stakeholder integration. Business Strategy and the Environment, 33(4), 2969-3004. https://doi.org/10.1002/bse.3630
48. Otte, E., & Rousseau, R. (2002). Social network analysis: a powerful strategy, also for the information sciences. Journal of information Science, 28(6), 441-453. https://doi.org/10.1177/016555150202800601
49. Panda, S., Kundu, K., Basaiahgari, A., Singh, A. P., Senapati, S., & Gardas, R. L. (2018). Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations. New Journal of Chemistry, 42(9), 7105–7118. https://doi.org/10.1039/c8nj00336j
50. Park, J., & Chung, E. (2021). Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea. World Development, 137(1), 105198. https://doi.org/10.1016/j.worlddev.2020.105198
51. Ramirez, J., Gallego, G., Ez, W. N. N. N., & Tirado, J. G. (2023). Blockchain Technology for Sustainable Supply Chains: A Bibliometric Study. Journal of Distribution Science, 21(6), 119-129. https://doi.org/10.15722/jds.21.06.202306.119
52. Ramírez-Duran, J. A., Niebles-Núñez, W., & García-Tirado, J. (2023). Aplicaciones bibliométricas del estudio del capital intelectual dentro de las instituciones de educación superior desde un enfoque sostenible. Saber, Ciencia y Libertad, 18(1). https://n9.cl/2ofg4
53. Sabat, K. C., Bhattacharyya, S. S., & Krishnamoorthy, B. (2022). Circular economy in pharmaceutical industry through the lens of stimulus organism response theory. European Business Review, 34(6), 936-964. https://doi.org/10.1108/EBR-02-2022-0037
54. Sarkis, M., Bernardi, A., Shah, N., & Papathanasiou, M. M. (2021). Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes, 9(3), 457. https://doi.org/10.3390/pr9030457
55. Sax, P., & Shmueli, A. (2010). Impact of pharmaceutical regulation and policies on health system performance goals in Israel. Advances in Health Economics and Health Services Research, 77–101. https://doi.org/10.1108/s0731-2199(2010)0000022007
56. Schneider, J. L., Wilson, A., & Rosenbeck, J. M. (2010). Pharmaceutical companies and sustainability: an analysis of corporate reporting. Benchmarking: An International Journal, 17(3), 421–434. https://doi.org/10.1108/14635771011049371
57. Singh, R. K., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chains: a review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3), 234–257. https://doi.org/10.1108/ijphm-10-2015-0050
58. Small, H. (1973). Co‐citation in the scientific literature: A new measure of the relationship between two documents. Journal of the American Society for information Science, 24(4), 265-269. https://doi.org/10.1002/asi.4630240406
59. Vargas, J., & González, D. (2016). Model to assess supply chain resilience. International Journal of Safety and Security Engineering, 6(2), 282-292. https://www.witpress.com/elibrary/SSE-volumes/6/2/1171
60. Vola, F., Vinci, B., Golinelli, D., Fantini, M. P., & Vainieri, M. (2020). Harnessing pharmaceutical innovation for anti-cancer drugs: Some findings from the Italian regions. Health Policy. https://doi.org/10.1016/j.healthpol.2020.07.016
61. Woutersa, O. J., & Kanavosa, P. G. (2015). Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93(1), 606-613. https://doi.org/10.2471/BLT.14.148742
62. Zaid, AA, Jaaron, AAM y Talib Bon, A. (2018). El impacto de la gestión verde de los recursos humanos y las prácticas verdes de gestión de la cadena de suministro en el desempeño sostenible: un estudio empírico. Revista de Producción Más Limpia. https://doi.org/10.1016/j.jclepro.2018.09.062
63. Zhu, Z., Wang, Q., Sun, Q., Lexchin, J., & Yang, L. (2023). Improving access to medicines and beyond: the national volume-based procurement policy in China. BMJ Global Health, 8(7), e011535. https://doi.org/10.1136/bmjgh-2022-011535
64. Zyoud, S. E. H., Al-Jabi, S. W., Sweileh, W. M., Al-Khalil, S., Alqub, M., & Awang, R. (2015). Global methaemoglobinaemia research output (1940–2013): a bibliometric analysis. Springerplus, 4(1), 1-7. https://doi.org/10.1186/s40064-015-1431-7
Article Sidebar
Published
May 13, 2023
Article Details
How to Cite
Yahilina Silveira Pérez, Claudia Rojas Martinez, & William Niebles Nuñez. (2023). PHARMACEUTICAL SECTOR AND SUSTAINABILITY. Journal of Population Therapeutics and Clinical Pharmacology, 30(10), 603-615. https://doi.org/10.53555/jptcp.v30i10.6694
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Yahilina Silveira Pérez
Universidad de Sucre (Colombia)
Claudia Rojas Martinez
Universidad de Sucre (Colombia)
William Niebles Nuñez
Universidad de Sucre (Colombia)
How to Cite
Yahilina Silveira Pérez, Claudia Rojas Martinez, & William Niebles Nuñez. (2023). PHARMACEUTICAL SECTOR AND SUSTAINABILITY. Journal of Population Therapeutics and Clinical Pharmacology, 30(10), 603-615. https://doi.org/10.53555/jptcp.v30i10.6694